The disconnect between the company's performance and share p...
The disconnect between the company's performance and share price hints at potential past overrating or a current investment opportunity. Long-term metric improvements are needed for better evaluations.
Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Shareholders Have Endured a 61% Loss From Investing in the Stock Three Years Ago
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment